Mincef S 500mg/250mg Injection
Marketer
Aeryn Lifesciences Pvt Ltd
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Mincef S 500mg/250mg Injection
Cefixime and Sulbactam injection (500mg/250mg), a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation. Administer this medication strictly as directed by your physician. Complete the prescribed course; premature cessation can compromise its effectiveness. Common side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening side effects or allergic reactions (rash, itching, swelling, respiratory distress) immediately. Inform your doctor of all other medications, and pregnant or breastfeeding individuals should seek medical advice before use. Alcohol consumption may increase drowsiness. While generally non-impairing to driving ability, avoid driving if experiencing drowsiness or dizziness. Adequate rest, nutrition, and hydration promote recovery. Your doctor might order tests to monitor the medication's impact.
Uses of Mincef S 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Mincef S 500mg/250mg Injection:
Administering this medication will be done by your physician or registered nurse; self-medication is strongly discouraged.
Common Side effects of Mincef S 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Mincef S 500mg/250mg Injection:
This medication will be administered by your physician or their qualified staff. Self-medication is strictly prohibited.
How Mincef S 500mg/250mg Injection works:
The injectable formulation Mincef S (500mg Ceftriaxone/250mg Sulbactam) combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Sulbactam. Ceftriaxone's antibacterial action disrupts bacterial cell wall synthesis, hindering their growth. Sulbactam counteracts bacterial resistance mechanisms, optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of alcohol and Mincef S 500mg/250mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Cefuroxime injection (500mg/250mg), marketed as Mincef S, is typically deemed safe for use in pregnancy. Preclinical trials using animal models revealed minimal or no harmful effects on fetal development; nevertheless, data from human trials remain scarce.
Breast feedingCAUTION
Cefixime (Mincef S 500mg/250mg Injection) necessitates careful consideration during lactation. Breastfeeding is advised against until maternal treatment concludes and the medication is fully cleared from the mother's system.
DrivingUNSAFE
The injection Mincef S (500mg/250mg) can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Mincef S 500mg/250mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Cefixime/Sulbactam injection (500mg/250mg) requires careful administration in patients exhibiting severe hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alterations for this injection are not suggested for individuals with mild or moderate liver dysfunction.
What if you forget to take Mincef S 500mg/250mg Injection :
Should you forget a scheduled dose of Mincef S 500mg/250mg Injection, seek medical advice.
Facts to Know About Mincef S 500mg/250mg Injection
| Label | Value |
|---|---|
| Addictive | None. |
| Medication Category | Antimicrobial Agents |
3,018 People bought this recently